15:58 Oct 09
Lupin Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Lupin Ltd.
84/100 High Financial Strength
Quality36/100 Mid Valuation
Valuation63/100 Technically Moderately Bullish
TechnicalSWOT
Strength
15
Weakness
1
Opportunity
3
Threat
3
1.04L
Market Cap (Cr)
46.07
PE Ratio
7.30
Price to Book Ratio
63.34
RSI
9.56 %
Net Profit Margin
Rating Based on 9 Analysts
Buy
44%
Hold
44%
Sell
11%
Buy
Analyst Price Target
The average price target is 1945.44 with a high estimate of 2443 and low estimate of 1600
Current 2286.05
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation
SWOT
Download Our App On:
